Article
Panelists agree that congress does not want these cuts in physician payment rates and Medicare.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Direct-to-Patient Apixaban Program Aims to Expand Access, Lower Out-of-Pocket Costs
Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD
Building a Better Future Through Technology, Advocacy, and Community
Managed Care Cast News Roundup: July 8, 2025
For Community Oncology, Good News in PFS Offset by Potential Wreckage of MFP Proposal
Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD